Skip to main content
unnamed
Menu
Home » Eye Care Services » Your Eye Health » Eye Diseases » Diabetes and Eyesight » Treatment for Diabetic Retinopathy

Treatment for Diabetic Retinopathy

95% of people diagnosed with diabetic retinopathy, if treated promptly, can avoid significant vision loss.

Laser photocoagulation treatment seals off blood vessels that are leaking into the eye, and stops new blood vessels from growing. This laser treatment only takes a few moments, and is painless.

Sometimes in diabetic retinopathy blood leaks into the vitreous humor in the eye, clouding vision. Some eye doctors wait before choosing treatment, as the blood may dissipate by itself. Another treatment option is a vitrectomy, which removes blood that has already leaked into the vitreous humor.

To improve the supply of blood to the core inner portion of the retina, a laser may be used to destroy tissue on the outside of the retina which is not essential for basic vision. This procedure is used to save vision.

Lucentis is a medication that is administered by an eye doctor using injections. This medication was approved by the FDA in 2015, and is the first non-laser treatment approved by the FDA. The FDA is currently reviewing several other non-laser treatments for diabetic retinopathy.

Please be aware that if you normally have OHIP coverage, ODSP coverage or OW coverage for your eye exams, we are unable to schedule an appointment for you at this time due to the current Ontario Association of Optometrists job action. You can help by visiting saveeyecare.ca which will let the Government of Ontario know that eye care is important to you and your family.

Our hours of operation have changed as we are currently seeing patients by appointment only for ALL visits (including glasses adjustments, etc). Please contact our office to book an appointment as needed.

We are continuing to follow health and safety guidelines as set out by the College of Optometrists of Ontario and the Government of Ontario.

x

Our office protocols have changed considerably due to the COVID-19 pandemic. Please refer to our COVID-19 Building Entry Policy